The number of people with susceptibility test result for rifampicin in Georgia
Georgia: The number of people with susceptibility test result for rifampicin was 953 in 2021. ▼ Falling
Latest (2021)
953
Change on year
down 10.4%
World rank
68th
of 155 countries
All-time high
1,442
in 2017
All-time low
953
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Georgia, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Georgia is 953, measured in 2021. That is the lowest value across all 5 years on record.
That represents a change of down 10.4% on the previous year and down 33.9% over five years.
Georgia ranks 68th of 155 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Georgia, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 1,442 | — |
| 2018 | 1,313 | -8.9% |
| 2019 | 1,360 | +3.6% |
| 2020 | 1,064 | -21.8% |
| 2021 | 953 | -10.4% |
Georgia compared with similar countries
- Georgia's 953 is above the median for upper middle income countries, which is 880, 1.1× the median. (46 countries reporting)
- Georgia's 953 is above the median for Europe & Central Asia, which is 229.5, 4.2× the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1,372 | 1,313 | 1,442 | 3 |
| 2020s | 1,008 | 953 | 1,064 | 2 |
Countries ranked near Georgia
More health data for Georgia
- Un projection of annual infant deaths, annual growth rate -3.7 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.0382 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,310 deaths per 1,000 people (2090)
- Number of infants who die before age 1 26 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.2207 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0286 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.2812 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Georgia?
- The number of people with susceptibility test result for rifampicin in Georgia was 953 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Georgia?
- The highest recorded value was 1,442 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Georgia?
- The lowest recorded value was 953 in 2021.
- How does Georgia rank for the number of people with susceptibility test result for rifampicin?
- Georgia ranks 68th out of 155 countries with data for 2021.
- Where does this Georgia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).